MEDP
Medpace Holdings Inc
NASDAQ: MEDP · HEALTHCARE · DIAGNOSTICS & RESEARCH
$413.59
+0.96% today
Updated 2026-04-29
Market cap
$11.81B
P/E ratio
26.04
P/S ratio
4.41x
EPS (TTM)
$15.88
Dividend yield
—
52W range
$284 – $629
Volume
0.4M
Medpace Holdings Inc (MEDP) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$413.59
12-Month target
$460.23
2030 Target
—
Intrinsic (DCF)
$402.51
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B | $3.0B | $3.6B | $4.4B | $5.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 17.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.